Page last updated: 2024-09-05

3-(2-carboxyindol-3-yl)propionic acid and Progeria

3-(2-carboxyindol-3-yl)propionic acid has been researched along with Progeria in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Daily, N; Elson, J; Wakatsuki, T1

Other Studies

1 other study(ies) available for 3-(2-carboxyindol-3-yl)propionic acid and Progeria

ArticleYear
Aging Model for Analyzing Drug-Induced Proarrhythmia Risks Using Cardiomyocytes Differentiated from Progeria-Patient-Derived Induced Pluripotent Stem Cells.
    International journal of molecular sciences, 2023, Jul-26, Volume: 24, Issue:15

    Topics: Aging; Animals; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Pharmaceutical Preparations; Progeria

2023